18.11.2020 • NewsElementis

Elementis Rejects Takeover Bid

Elementis has rejected a takeover bid from US specialty minerals firm Minerals Technologies Inc (MTI).

The New York City-based group revealed that it had made a bid on Nov. 5 to acquire the UK specialty chemicals firm, but the Elementis board rebuffed the all-cash offer, stating it significantly undervalued the firm and its future prospects.

The bid of $1.41 per share represented a 31% premium over Elementis’ share price on Nov. 4.

According to UK law, MTI now has until Dec. 10 to state whether or not it intends to make a formal and public offer for Elementis.

Both companies supply materials derived from mined minerals. Elementis also produces specialty chemicals for consumer and industrial applications and regards itself as the leading global producer of chromium chemicals. It reported sales of $874 million last year.

With annual sales of about $1.8 billion, MTI is a leading supplier of bentonite and bentonite-related products, as well as chromite and leonardite, to industrial and consumer markets globally. It also produces and sells synthetic mineral product precipitated calcium carbonate (PCC).

MTI said it is now considering its position, adding that there is no certainty that it will make any further proposal or firm offer, although any offer would likely be solely in cash.

Author: Elaine Burridge, Freelance Journalist

Elementis has rejected a takeover bid from US specialty minerals firm Minerals...
Elementis has rejected a takeover bid from US specialty minerals firm Minerals Technologies Inc (MTI). According to UK law, MTI now has until Dec. 10 to state whether or not it intends to make a formal and public offer for the UK specialty chemicals firm. (c) Khoa

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.